...
首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >Huangzhi Oral Liquid Prevents Arrhythmias by Upregulating Caspase-3 and Apoptosis Network Proteins in Myocardial Ischemia-Reperfusion Injury in Rats
【24h】

Huangzhi Oral Liquid Prevents Arrhythmias by Upregulating Caspase-3 and Apoptosis Network Proteins in Myocardial Ischemia-Reperfusion Injury in Rats

机译:皇芝口服液通过上调大鼠心肌缺血再灌注损伤中的Caspase-3和凋亡网络蛋白来预防心律失常

获取原文
           

摘要

To study the effect of Huangzhi oral liquid (HZOL) on I/R after 2 h and 4 h and determine its regulatory function on caspase-3 and protein networks. 70 SD male rats were randomly divided into seven groups and established myocardial I/R injury model by ligating the left anterior descending coronary artery. Myocardial infarction model was defined by TTC staining and color of the heart. The levels of CK-MB, CTnI, C-RPL, SOD, and MDA were tested at 2 h and 4 h after reperfusion. HE staining and ultramicrostructural were used to observe the pathological changes. The apoptotic index (AI) of cardiomyocyte was marked by TUNEL. The expression levels of caspase-3, p53, fas, Bcl-2, and Bax were tested by immunohistochemistry and western blot. HZOL corrected arrhythmia, improved the pathologic abnormalities, decreased CK-MB, CTnI, C-RPL, MDA, AI, caspase-3, p53, fas, and Bax, and increased SOD ans Bcl-2 with different times of myocardial reperfusion; this result was similar to the ISMOC (P>0.05). HZOL could inhibit arrhythmia at 2 and 4 h after I/R and ameliorate cardiac function, which was more significant at 4 h after reperfusion. This result may be related to decreased expression of caspase-3, p53, and fas and increased Bcl-2/Bax ratio.
机译:研究黄zhi口服液(HZOL)对2 h和4 h后I / R的影响,并确定其对caspase-3和蛋白质网络的调节功能。将70只SD雄性大鼠随机分为7组,结扎左冠状动脉前降支,建立心肌I / R损伤模型。心肌梗塞模型由TTC染色和心脏颜色定义。再灌注后2 h和4 h检测CK-MB,CTnI,C-RPL,SOD和MDA的水平。 HE染色和超微结构观察病理变化。 TUNEL标记心肌细胞的凋亡指数(AI)。通过免疫组织化学和western blot检测caspase-3,p53,fas,Bcl-2和Bax的表达水平。 HZOL纠正了心律失常,改善了病理异常,降低了CK-MB,CTnI,C-RPL,MDA,AI,caspase-3,p53,fas和Bax的含量,并增加了SOD和Bcl-2的含量,这与不同时间的心肌再灌注有关;该结果类似于ISMOC(P> 0.05)。 HZOL可以在I / R后2和4 h抑制心律不齐,改善心功能,在再灌注后4 h更为明显。此结果可能与caspase-3,p53和fas的表达减少以及Bcl-2 / Bax比率增加有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号